SDGRSchrodinger, Inc.
- Market cap
- $1.78B
- as of 2026-10-23
- Latest close
- $23.80
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Health Information Services
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-02-13
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Akinsanya KarenSee Remarks | Sep 17 | Sep 21 | M | 31,599 | $4.34 | $137,140 | 101,555 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Sep 17 | Sep 21 | S | 10,000 | $28.00 | Sale −$280,000 | 91,555 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Sep 17 | Sep 21 | S | 21,599 | $30.00 | Sale −$647,970 | 69,956 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Sep 17 | Sep 21 | M · derivative | 31,599 | $4.34 | $137,140 | 11,599 | Yes | Form 4 |
| Jain RachitEVP & CFO | Jul 16 | Jul 17 | S | 875 | $15.60 | Sale −$13,650 | 50,877 | Yes | Form 4 |
| Friesner Richard | Jun 26 | Jun 29 | G | 679,373 | $0.00 | $0 | not reported | No | Form 4 |
| Friesner Richard | Jun 26 | Jun 29 | G | 679,373 | $0.00 | $0 | 679,373 | No | Form 4 |
| Ginsberg Gary L | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 25,388 | No | Form 4 |
| Ginsberg Gary L | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| Oberoi Arun | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 25,388 | No | Form 4 |
| Oberoi Arun | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| van Kralingen Bridget A | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 19,640 | No | Form 4 |
| van Kralingen Bridget A | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| Lynton Michael | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 25,388 | No | Form 4 |
| Lynton Michael | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| Chodakewitz Jeffrey | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 25,388 | No | Form 4 |
| Chodakewitz Jeffrey | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| Sender Gary | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 25,388 | No | Form 4 |
| Sender Gary | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| Thornberry Nancy | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 25,388 | No | Form 4 |
| Thornberry Nancy | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| Kapeller-Libermann Rosana | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 25,388 | No | Form 4 |
| Kapeller-Libermann Rosana | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| Friesner Richard | Jun 22 | Jun 23 | A | 8,141 | $0.00 | $0 | 690,365 | No | Form 4 |
| Friesner Richard | Jun 22 | Jun 23 | A · derivative | 13,313 | $15.23 | $202,757 | 13,313 | No | Form 4 |
| Farid RamyPresident & CEO | Apr 17 | Apr 17 | M | 43,000 | $3.07 | $132,010 | 373,824 | Yes | Form 4 |
| Farid RamyPresident & CEO | Apr 17 | Apr 17 | S | 43,000 | $12.21 | Sale −$525,030 | 330,824 | Yes | Form 4 |
| Farid RamyPresident & CEO | Apr 17 | Apr 17 | M | 74,527 | $3.07 | $228,798 | 405,351 | Yes | Form 4 |
| Farid RamyPresident & CEO | Apr 17 | Apr 17 | M · derivative | 43,000 | $3.07 | $132,010 | 74,527 | Yes | Form 4 |
| Farid RamyPresident & CEO | Apr 17 | Apr 17 | M · derivative | 74,527 | $3.07 | $228,798 | not reported | Yes | Form 4 |
| Farid RamyPresident & CEO | Apr 16 | Apr 17 | M | 43,000 | $3.07 | $132,010 | 373,824 | Yes | Form 4 |
| Farid RamyPresident & CEO | Apr 16 | Apr 17 | S | 43,000 | $12.33 | Sale −$530,190 | 330,824 | Yes | Form 4 |
| Farid RamyPresident & CEO | Apr 16 | Apr 17 | M · derivative | 43,000 | $3.07 | $132,010 | 117,527 | Yes | Form 4 |
| Jain RachitEVP & CFO | Apr 16 | Apr 17 | S | 844 | $12.75 | Sale −$10,761 | 51,752 | Yes | Form 4 |
| Herman JennyCAO | Mar 6 | Mar 6 | S | 608 | $12.84 | Sale −$7,807 | 34,804 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Mar 5 | Mar 6 | S | 1,366 | $12.90 | Sale −$17,621 | 69,956 | Yes | Form 4 |
| Farid RamyPresident & CEO | Mar 5 | Mar 6 | S | 3,661 | $12.91 | Sale −$47,264 | 330,824 | Yes | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 5 | Mar 6 | S | 1,222 | $12.90 | Sale −$15,764 | 89,241 | Yes | Form 4 |
| Tran YvonneEVP, CLO & CPO | Mar 5 | Mar 6 | S | 1,094 | $12.90 | Sale −$14,113 | 52,683 | Yes | Form 4 |
| Herman JennyCAO | Mar 5 | Mar 6 | S | 775 | $12.85 | Sale −$9,959 | 35,412 | Yes | Form 4 |
| Jain RachitEVP & CFO | Mar 5 | Mar 6 | S | 1,631 | $12.90 | Sale −$21,040 | 52,596 | Yes | Form 4 |
| Abel Robert LorneSee Remarks | Mar 4 | Mar 6 | S | 1,300 | $12.81 | Sale −$16,653 | 55,897 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Mar 2 | Mar 3 | A | 24,250 | $0.00 | $0 | 39,875 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Mar 2 | Mar 3 | A | 6,077 | $0.00 | $0 | 45,952 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Mar 2 | Mar 3 | A | 27,576 | $0.00 | $0 | 73,528 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Mar 2 | Mar 3 | S | 2,206 | $11.99 | Sale −$26,450 | 71,322 | Yes | Form 4 |
| Akinsanya KarenSee Remarks | Mar 2 | Mar 3 | A · derivative | 48,500 | $12.15 | $589,275 | 48,500 | Yes | Form 4 |
| Farid RamyPresident & CEO | Mar 2 | Mar 3 | A | 56,250 | $0.00 | $0 | 278,182 | Yes | Form 4 |
| Farid RamyPresident & CEO | Mar 2 | Mar 3 | A | 13,604 | $0.00 | $0 | 291,786 | Yes | Form 4 |
| Farid RamyPresident & CEO | Mar 2 | Mar 3 | A | 48,259 | $0.00 | $0 | 340,045 | Yes | Form 4 |
| Farid RamyPresident & CEO | Mar 2 | Mar 3 | S | 5,560 | $11.90 | Sale −$66,164 | 334,485 | Yes | Form 4 |
| Farid RamyPresident & CEO | Mar 2 | Mar 3 | A · derivative | 112,500 | $12.15 | $1,366,875 | 112,500 | Yes | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 2 | Mar 3 | A | 17,130 | $0.00 | $0 | 69,781 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 2 | Mar 3 | A | 20,682 | $0.00 | $0 | 90,463 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 2 | Mar 3 | A · derivative | 34,250 | $12.15 | $416,138 | 34,250 | No | Form 4 |
| Tran YvonneEVP, CLO & CPO | Mar 2 | Mar 3 | A | 17,130 | $0.00 | $0 | 39,989 | No | Form 4 |
| Tran YvonneEVP, CLO & CPO | Mar 2 | Mar 3 | A | 13,788 | $0.00 | $0 | 53,777 | No | Form 4 |
| Tran YvonneEVP, CLO & CPO | Mar 2 | Mar 3 | A · derivative | 34,250 | $12.15 | $416,138 | 34,250 | No | Form 4 |
| Herman JennyCAO | Mar 2 | Mar 3 | A | 9,590 | $0.00 | $0 | 36,187 | No | Form 4 |
| Herman JennyCAO | Mar 2 | Mar 3 | A · derivative | 8,220 | $12.15 | $99,873 | 8,220 | No | Form 4 |
| Abel Robert LorneSee Remarks | Mar 2 | Mar 3 | A | 17,130 | $0.00 | $0 | 36,515 | No | Form 4 |
| Abel Robert LorneSee Remarks | Mar 2 | Mar 3 | A | 20,682 | $0.00 | $0 | 57,197 | No | Form 4 |
| Abel Robert LorneSee Remarks | Mar 2 | Mar 3 | A · derivative | 34,250 | $12.15 | $416,138 | 34,250 | No | Form 4 |
| Friesner Richard | Mar 2 | Mar 3 | M | 160,527 | $3.07 | $492,818 | 682,224 | No | Form 4 |
| Friesner Richard | Mar 2 | Mar 3 | M · derivative | 160,527 | $3.07 | $492,818 | not reported | No | Form 4 |
| Aklian Mannix VartanSee Remarks | Mar 2 | Mar 3 | A | 17,130 | $0.00 | $0 | 31,193 | No | Form 4 |
| Aklian Mannix VartanSee Remarks | Mar 2 | Mar 3 | A · derivative | 34,250 | $12.15 | $416,138 | 34,250 | No | Form 4 |
| Jain RachitEVP & CFO | Mar 2 | Mar 3 | A | 17,130 | $0.00 | $0 | 54,227 | No | Form 4 |
| Jain RachitEVP & CFO | Mar 2 | Mar 3 | A · derivative | 34,250 | $12.15 | $416,138 | 34,250 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Feb 10 | Feb 12 | S | 925 | $13.73 | Sale −$12,700 | 52,651 | Yes | Form 4 |
| Tran YvonneEVP, CLO & CPO | Feb 10 | Feb 12 | S | 776 | $13.80 | Sale −$10,709 | 22,859 | Yes | Form 4 |
| Herman JennyCAO | Feb 10 | Feb 12 | S | 752 | $13.79 | Sale −$10,370 | 26,597 | Yes | Form 4 |
| Abel Robert LorneSee Remarks | Feb 9 | Feb 11 | S | 1,230 | $13.51 | Sale −$16,617 | 19,385 | Yes | Form 4 |
| Dugan MargaretChief Medical Officer | Oct 16, 2025 | Oct 17, 2025 | S | 1,395 | $21.07 | Sale −$29,393 | 24,574 | Yes | Form 4 |
| Friesner Richard | Jun 18, 2025 | Jun 20, 2025 | A | 5,997 | $0.00 | $0 | 521,697 | No | Form 4 |
| Friesner Richard | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 9,341 | $21.05 | $196,628 | 9,341 | No | Form 4 |
| Oberoi Arun | Jun 18, 2025 | Jun 20, 2025 | A | 5,997 | $0.00 | $0 | 17,247 | No | Form 4 |
| Oberoi Arun | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 9,341 | $21.05 | $196,628 | 9,341 | No | Form 4 |
| Ginsberg Gary L | Jun 18, 2025 | Jun 20, 2025 | A | 5,997 | $0.00 | $0 | 17,247 | No | Form 4 |
| Ginsberg Gary L | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 9,341 | $21.05 | $196,628 | 9,341 | No | Form 4 |
| Kapeller-Libermann Rosana | Jun 18, 2025 | Jun 20, 2025 | A | 5,997 | $0.00 | $0 | 17,247 | No | Form 4 |
| Kapeller-Libermann Rosana | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 9,341 | $21.05 | $196,628 | 9,341 | No | Form 4 |
| Thornberry Nancy | Jun 18, 2025 | Jun 20, 2025 | A | 5,997 | $0.00 | $0 | 17,247 | No | Form 4 |
| Thornberry Nancy | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 9,341 | $21.05 | $196,628 | 9,341 | No | Form 4 |
| van Kralingen Bridget A | Jun 18, 2025 | Jun 20, 2025 | A | 1,499 | $0.00 | $0 | 11,499 | No | Form 4 |
| van Kralingen Bridget A | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 2,335 | $21.05 | $49,152 | 2,335 | No | Form 4 |
| Lynton Michael | Jun 18, 2025 | Jun 20, 2025 | A | 5,997 | $0.00 | $0 | 17,247 | No | Form 4 |
| Lynton Michael | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 9,341 | $21.05 | $196,628 | 9,341 | No | Form 4 |
| Sender Gary | Jun 18, 2025 | Jun 20, 2025 | A | 5,997 | $0.00 | $0 | 17,247 | No | Form 4 |
| Sender Gary | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 9,341 | $21.05 | $196,628 | 9,341 | No | Form 4 |
| Chodakewitz Jeffrey | Jun 18, 2025 | Jun 20, 2025 | A | 5,997 | $0.00 | $0 | 17,247 | No | Form 4 |
| Chodakewitz Jeffrey | Jun 18, 2025 | Jun 20, 2025 | A · derivative | 9,341 | $21.05 | $196,628 | 9,341 | No | Form 4 |
| Aklian Mannix VartanSee Remarks | May 29, 2025 | May 29, 2025 | A | 14,063 | $0.00 | $0 | 14,063 | No | Form 4 |
| Aklian Mannix VartanSee Remarks | May 29, 2025 | May 29, 2025 | A · derivative | 84,375 | $21.44 | $1,809,000 | 84,375 | No | Form 4 |
| Jain RachitEVP & CFO | May 21, 2025 | May 22, 2025 | A | 9,375 | $0.00 | $0 | 37,097 | No | Form 4 |
| Jain RachitEVP & CFO | May 21, 2025 | May 22, 2025 | A · derivative | 18,750 | $20.51 | $384,563 | 18,750 | No | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Apr 14, 2025 | Apr 15, 2025 | M | 13,378 | $3.22 | $43,077 | 29,003 | Yes | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Apr 14, 2025 | Apr 15, 2025 | M | 3,345 | $2.92 | $9,767 | 32,348 | Yes | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Apr 14, 2025 | Apr 15, 2025 | S | 8,378 | $25.11 | Sale −$210,372 | 23,970 | Yes | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Apr 14, 2025 | Apr 15, 2025 | S | 5,000 | $25.11 | Sale −$125,550 | 18,970 | Yes | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Apr 14, 2025 | Apr 15, 2025 | S | 3,345 | $25.00 | Sale −$83,625 | 15,625 | Yes | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Apr 14, 2025 | Apr 15, 2025 | M · derivative | 13,378 | $3.22 | $43,077 | not reported | Yes | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Apr 14, 2025 | Apr 15, 2025 | M · derivative | 3,345 | $2.92 | $9,767 | not reported | Yes | Form 4 |
| van Kralingen Bridget A | Mar 7, 2025 | Mar 10, 2025 | A | 10,000 | $0.00 | $0 | 10,000 | No | Form 4 |
| van Kralingen Bridget A | Mar 7, 2025 | Mar 10, 2025 | A · derivative | 17,050 | $21.02 | $358,391 | 17,050 | No | Form 4 |
| Herman JennySVP & Controller | Mar 6, 2025 | Mar 7, 2025 | S | 666 | $21.11 | Sale −$14,059 | 27,349 | Yes | Form 4 |
| Abel Robert LorneSee Remarks | Mar 3, 2025 | Mar 4, 2025 | A | 12,500 | $0.00 | $0 | 20,615 | No | Form 4 |
| Abel Robert LorneSee Remarks | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 50,000 | $21.24 | $1,062,000 | 50,000 | No | Form 4 |
| Tran YvonneEVP, CLO & CPO | Mar 3, 2025 | Mar 4, 2025 | A | 12,500 | $0.00 | $0 | 23,635 | No | Form 4 |
| Tran YvonneEVP, CLO & CPO | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 50,000 | $21.24 | $1,062,000 | 50,000 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 3, 2025 | Mar 4, 2025 | A | 12,500 | $0.00 | $0 | 53,576 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 50,000 | $21.24 | $1,062,000 | 50,000 | No | Form 4 |
| Herman JennySVP & Controller | Mar 3, 2025 | Mar 4, 2025 | A | 9,800 | $0.00 | $0 | 28,015 | No | Form 4 |
| Herman JennySVP & Controller | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 8,400 | $21.24 | $178,416 | 8,400 | No | Form 4 |
| Dugan MargaretChief Medical Officer | Mar 3, 2025 | Mar 4, 2025 | A | 12,500 | $0.00 | $0 | 25,969 | No | Form 4 |
| Dugan MargaretChief Medical Officer | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 50,000 | $21.24 | $1,062,000 | 50,000 | No | Form 4 |
| Farid RamyPresident & CEO | Mar 3, 2025 | Mar 4, 2025 | A | 37,500 | $0.00 | $0 | 221,932 | No | Form 4 |
| Farid RamyPresident & CEO | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 60,000 | $21.24 | $1,274,400 | 60,000 | No | Form 4 |
| Farid RamyPresident & CEO | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 90,000 | $23.36 | $2,102,400 | 90,000 | No | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Mar 3, 2025 | Mar 4, 2025 | A | 15,625 | $0.00 | $0 | 15,625 | No | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 62,500 | $21.24 | $1,327,500 | 62,500 | No | Form 4 |
| Porges Geoffrey CraigEVP & CFO | Mar 3, 2025 | Mar 4, 2025 | A | 12,500 | $0.00 | $0 | 18,185 | No | Form 4 |
| Porges Geoffrey CraigEVP & CFO | Mar 3, 2025 | Mar 4, 2025 | A | 14,850 | $0.00 | $0 | 33,035 | No | Form 4 |
| Porges Geoffrey CraigEVP & CFO | Mar 3, 2025 | Mar 4, 2025 | S | 5,491 | $21.76 | Sale −$119,484 | 27,544 | No | Form 4 |
| Porges Geoffrey CraigEVP & CFO | Mar 3, 2025 | Mar 4, 2025 | A · derivative | 50,000 | $21.24 | $1,062,000 | 50,000 | No | Form 4 |
| Tran YvonneEVP, CLO & CPO | Feb 18, 2025 | Feb 19, 2025 | M | 3,902 | $4.34 | $16,935 | 15,037 | Yes | Form 4 |
| Tran YvonneEVP, CLO & CPO | Feb 18, 2025 | Feb 19, 2025 | S | 3,902 | $28.00 | Sale −$109,256 | 11,135 | Yes | Form 4 |
| Tran YvonneEVP, CLO & CPO | Feb 18, 2025 | Feb 19, 2025 | M · derivative | 3,902 | $4.34 | $16,935 | not reported | Yes | Form 4 |
| Tran YvonneEVP, CLO & CPO | Feb 11, 2025 | Feb 12, 2025 | S | 828 | $24.43 | Sale −$20,228 | 11,135 | Yes | Form 4 |
| Herman JennySVP & Controller | Feb 11, 2025 | Feb 12, 2025 | S | 859 | $24.43 | Sale −$20,985 | 18,215 | Yes | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Feb 11, 2025 | Feb 12, 2025 | S | 985 | $24.43 | Sale −$24,064 | 41,076 | Yes | Form 4 |
| Abel Robert LorneSee Remarks | Feb 10, 2025 | Feb 12, 2025 | S | 1,225 | $25.99 | Sale −$31,838 | 8,115 | Yes | Form 4 |
| Dugan MargaretChief Medical Officer | Oct 15, 2024 | Oct 16, 2024 | S | 1,531 | $17.78 | Sale −$27,221 | 13,469 | Yes | Form 4 |
| Ginsberg Gary L | Jun 18, 2024 | Jun 20, 2024 | A | 5,000 | $0.00 | $0 | 11,250 | No | Form 4 |
| Ginsberg Gary L | Jun 18, 2024 | Jun 20, 2024 | A · derivative | 8,550 | $19.32 | $165,186 | 8,550 | No | Form 4 |
| Friesner Richard | Jun 18, 2024 | Jun 20, 2024 | A | 5,000 | $0.00 | $0 | 515,700 | No | Form 4 |
| Friesner Richard | Jun 18, 2024 | Jun 20, 2024 | A · derivative | 8,550 | $19.32 | $165,186 | 8,550 | No | Form 4 |
| Thornberry Nancy | Jun 18, 2024 | Jun 20, 2024 | A | 5,000 | $0.00 | $0 | 11,250 | No | Form 4 |
| Thornberry Nancy | Jun 18, 2024 | Jun 20, 2024 | A · derivative | 8,550 | $19.32 | $165,186 | 8,550 | No | Form 4 |
| Sender Gary | Jun 18, 2024 | Jun 20, 2024 | A | 5,000 | $0.00 | $0 | 11,250 | No | Form 4 |
| Sender Gary | Jun 18, 2024 | Jun 20, 2024 | A · derivative | 8,550 | $19.32 | $165,186 | 8,550 | No | Form 4 |
| Oberoi Arun | Jun 18, 2024 | Jun 20, 2024 | A | 5,000 | $0.00 | $0 | 11,250 | No | Form 4 |
| Oberoi Arun | Jun 18, 2024 | Jun 20, 2024 | A · derivative | 8,550 | $19.32 | $165,186 | 8,550 | No | Form 4 |
| Lynton Michael | Jun 18, 2024 | Jun 20, 2024 | A | 5,000 | $0.00 | $0 | 11,250 | No | Form 4 |
| Lynton Michael | Jun 18, 2024 | Jun 20, 2024 | A · derivative | 8,550 | $19.32 | $165,186 | 8,550 | No | Form 4 |
| Kapeller-Libermann Rosana | Jun 18, 2024 | Jun 20, 2024 | A | 5,000 | $0.00 | $0 | 11,250 | No | Form 4 |
| Kapeller-Libermann Rosana | Jun 18, 2024 | Jun 20, 2024 | A · derivative | 8,550 | $19.32 | $165,186 | 8,550 | No | Form 4 |
| Chodakewitz Jeffrey | Jun 18, 2024 | Jun 20, 2024 | A | 5,000 | $0.00 | $0 | 11,250 | No | Form 4 |
| Chodakewitz Jeffrey | Jun 18, 2024 | Jun 20, 2024 | A · derivative | 8,550 | $19.32 | $165,186 | 8,550 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 21, 2024 | Mar 22, 2024 | A · derivative | 30,000 | $27.51 | $825,300 | 30,000 | No | Form 4 |
| Abel Robert LorneSee Remarks | Mar 21, 2024 | Mar 22, 2024 | A · derivative | 30,000 | $27.51 | $825,300 | 30,000 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 6, 2024 | Mar 7, 2024 | M | 5,574 | $4.34 | $24,191 | 42,061 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 6, 2024 | Mar 7, 2024 | M · derivative | 5,574 | $4.34 | $24,191 | not reported | No | Form 4 |
| Abel Robert LorneSee Remarks | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 60,000 | $25.24 | $1,514,400 | 60,000 | No | Form 4 |
| Dugan MargaretChief Medical Officer | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 60,000 | $25.24 | $1,514,400 | 60,000 | No | Form 4 |
| Tran YvonneEVP, CLO & CPO | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 60,000 | $25.24 | $1,514,400 | 60,000 | No | Form 4 |
| Akinsanya KarenPresident of R&D, Therapeutics | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 120,000 | $25.24 | $3,028,800 | 120,000 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 60,000 | $25.24 | $1,514,400 | 60,000 | No | Form 4 |
| Herman JennySVP & Controller | Mar 4, 2024 | Mar 5, 2024 | A | 7,313 | $0.00 | $0 | 19,074 | No | Form 4 |
| Herman JennySVP & Controller | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 14,625 | $25.24 | $369,135 | 14,625 | No | Form 4 |
| Farid RamyPresident & CEO | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 126,000 | $25.24 | $3,180,240 | 126,000 | No | Form 4 |
| Farid RamyPresident & CEO | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 87,271 | $27.76 | $2,422,643 | 87,271 | No | Form 4 |
| Porges Geoffrey CraigEVP & CFO | Mar 4, 2024 | Mar 5, 2024 | A | 9,000 | $0.00 | $0 | 9,000 | No | Form 4 |
| Porges Geoffrey CraigEVP & CFO | Mar 4, 2024 | Mar 5, 2024 | S | 3,315 | $26.35 | Sale −$87,350 | 5,685 | No | Form 4 |
| Porges Geoffrey CraigEVP & CFO | Mar 4, 2024 | Mar 5, 2024 | A · derivative | 90,000 | $25.24 | $2,271,600 | 90,000 | No | Form 4 |
| Lorton Kenneth PatrickEVP, CTO & COO, Software | Feb 12, 2024 | Feb 13, 2024 | S | 901 | $28.29 | Sale −$25,489 | 36,487 | Yes | Form 4 |
| Herman JennySVP & Controller | Feb 12, 2024 | Feb 13, 2024 | S | 787 | $28.29 | Sale −$22,264 | 11,761 | Yes | Form 4 |
| Abel Robert LorneSee Remarks | Feb 12, 2024 | Feb 13, 2024 | S | 1,205 | $27.55 | Sale −$33,198 | 9,340 | Yes | Form 4 |
| Tran YvonneEVP, CLO & CPO | Feb 12, 2024 | Feb 13, 2024 | S | 758 | $28.29 | Sale −$21,444 | 11,963 | Yes | Form 4 |